BamSEC and AlphaSense Join Forces
Learn More

PLUS THERAPEUTICS Inc.

NASDAQ: PSTV    
Share price (11/21/24): $1.20    
Market cap (11/21/24): $7.076 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.15
from S-1 1 page Third Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan June 6, 2024
12/34/56
EX-10.3
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 9 pages First Amendment to Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 50 pages Securities Purchase Agreement Section 1. Definitions
12/34/56
EX-10
from 8-K 28 pages Plus Therapeutics, Inc. 2020 Stock Incentive Plan Adopted by the Board of Directors on April 30, 2020 Approved by the Stockholders on June 16, 2020 Amended and Restated by the Board of Directors on March 22, 2021 Approved by the Stockholders on May 17, 2021 Further Amended and Restated by the Board of Directors on March 28, 2022 Approved by the Stockholders on May 16, 2022 Further Amended and Restated by the Board of Directors on February 24, 2023 Approved by the Stockholders on April 20, 2023
12/34/56
EX-10.1
from 8-K 6 pages Plus Therapeutics, Inc. Series F Preferred Stock Subscription and Investment Representation Agreement
12/34/56
EX-10.1
from 8-K 34 pages State of Texas County of Travis
12/34/56
EX-10.2
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 44 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 21 pages Plus Therapeutics, Inc. 2020 Stock Incentive Plan Adopted by the Board of Directors on April 30, 2020 Approved by the Stockholders on June 16, 2020 Amended and Restated by the Board of Directors on March 22, 2021 Approved by the Stockholders on May 17, 2021 Further Amended and Restated by the Board of Directors on March 28, 2022 Approved by the Stockholders on May 16, 2022 - I
12/34/56
EX-10.1
from 10-Q 12 pages Execution Medidata Services Agreement
12/34/56
EX-10.26
from 10-K 11 pages Plus Therapeutics, Inc. 2020 Stock Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.2
from 10-K 31 pages Patent & Technology License Agreement Agt. No. Hsc-1555-La1
12/34/56
EX-10.1
from 8-K 13 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 28 pages Plus Therapeutics, Inc. 2020 Stock Incentive Plan Adopted by the Board of Directors on April 30, 2020 Approved by the Stockholders on June 16, 2020 Amended and Restated by the Board of Directors on March 22, 2021 Approved by the Stockholders on May 17, 2021
12/34/56
EX-10.24
from 10-K 14 pages Master Services Agreement
12/34/56
EX-10.2
from 8-K 13 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 36 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 28 pages Plus Therapeutics, Inc. 2020 Stock Incentive Plan Adopted by the Board of Directors on April 30, 2020 Approved by the Stockholders on June 16, 2020 Plus Therapeutics, Inc. 2020 Stock Incentive Plan - I
12/34/56
EX-10.7
from 10-Q 19 pages Amended and Restated Employment Agreement
12/34/56